⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.

Telmisartan

تلمیسارتان

⚠ Unverified

❤️ Cardiovascular SystemAngiotensin receptor blocker

🤰 Pregnancy:Dangerous / avoid 🤱 Breastfeeding:Use with caution 👶 Children:Safety not established 👴 Older adults:Use with caution 🇮🇷 Registered in Iran ⛔ 2 contraindications 🇺🇸 FDA approved generic (ANDA) ANDA202130 ATC C09CA07

Market / country: 🇺🇸 USA

Micardis (US)

🧮 Dose calculator

Disease / regimen

Hypertension · Regimen source: FDA Telmisartan · 2.1

• Range 40–80 mg; dose-related response from 20 to 80 mg. FDA Telmisartan · 2.1

Formulation

Age *

Weight (kg) (optional)

Enter age (weight is optional for this regimen).

🛡️ Safety & information

Contraindications

⛔ Hypersensitivity (anaphylaxis or angioedema) to telmisartan. FDA Telmisartan · 4
⚠️ Boxed warning: fetal toxicity — stop as soon as pregnancy is detected. FDA Telmisartan · Boxed Warning

Formulations

20 mg tablet — tablet 🇺🇸 USA FDA Telmisartan · 3
40 mg tablet — tablet 🇺🇸 USA FDA Telmisartan · 3
80 mg tablet — tablet 🇺🇸 USA FDA Telmisartan · 3

👥 Special populations

🤰 PregnancyDangerous / avoid
Label: can cause fetal harm. Dangerous in pregnancy. FDA Telmisartan · Boxed Warning
“WARNING: FETAL TOXICITY See full prescribing information for complete boxed warnings.”
🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Telmisartan · 8.2
“Risk Summary There is no information regarding the presence of telmisartan in human milk, the effects on the breastfed infant, or the effects on milk production.”
👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Telmisartan · 8.4
“Safety and effectiveness in pediatric patients have not been established [see Clinical Pharmacology (12.3)].”
👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Telmisartan · 8.5
“Of the total number of patients receiving telmisartan in hypertension clinical studies, 551 (19%) were 65 to 74 years of age and 130 (4%) were 75 years or older.”
⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.

🔗 Reference links

FDA (approval record)ANDA202130
DailyMed (FDA label)FDA Telmisartan
MedlinePlus (NIH)Telmisartan
WHO ATC/DDDC09CA07
Darooyab (Iran)Telmisartan

🇮🇷 Registered in Iran Darooyab · G-1897/Telmisartan

Dosage forms with Iranian generic codes, per Darooyab.

53007 · TELMISARTAN TABLET ORAL 40 mg · قرص تلمیسارتان ۴۰ میلی‌گرم
53006 · TELMISARTAN TABLET ORAL 20 mg · قرص تلمیسارتان ۲۰ میلی‌گرم
53008 · TELMISARTAN TABLET ORAL 80 mg · قرص تلمیسارتان ۸۰ میلی‌گرم

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

FDA label (DailyMed)✅ Present
FDA Telmisartan · 3 FDA Telmisartan · 2.1 FDA Telmisartan · 2 FDA Telmisartan · 8.4 FDA Telmisartan · 4 FDA Telmisartan · Boxed Warning FDA Telmisartan · 8.2 FDA Telmisartan · 8.5 FDA Telmisartan · SPL approval / marketing category
UK SmPC (eMC / MHRA)❌ Not present
Published guideline❌ Not present
Licensed reference (medical school)❌ Not present
Iranian leaflet (IFDA)❌ Not present
Pharmacy website (secondary, unreliable)✅ Present
Darooyab · G-1897/Telmisartan
Clinical review⚠ Unverified